Pacira BioSciences, Inc.

NASDAQ (USD): Pacira BioSciences, Inc. (PCRX)

Last Price

21.06

Today's Change

-0.60 (2.77%)

Day's Change

20.82 - 21.59

Trading Volume

1,173,294

Profile
PCRX

Exchange:  NASDAQ Global Select NASDAQ Global Select

Currency:  USD USD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Mr. Frank D. Lee Mr. Frank D. Lee

Full Time Employees:  711 711

IPO Date:  2011-02-03 2011-02-03

CIK:  0001396814 0001396814

ISIN:  US6951271005 US6951271005

CUSIP:  695127100 695127100

Beta:  0.88 0.88

Last Dividend:  0.00 0.00

Dcf Diff:  -34.67 -34.67

Dcf:  63.13 63.13

Description

Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.

Address

5401 West Kennedy Boulevard,
Tampa, FL 33609, US

813 553 6680

http://www.pacira.com

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment